Pardes Biosciences (PRDS) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Pardes Biosciences Inc Ordinary Shares currently pays no dividends. ISIN: USQ WKN: A3C9K5. Pardes Biosciences, Inc. - Price History ; December , $, $ ; November , $, $ ; October , $, $ ; September , $, $ Stock/Option, Shares, Shares Change, Price, Cost, Final Share. Anna Hannah. Chief Executive Officer. 01/01/ Sell. Option. K. %. $ $, Pursuant to the terms of the Merger Agreement, prior to the Offer Closing Time, each share of Pardes' unvested restricted stock (the “Company Restricted Shares”).
News for Pardes Biosciences Inc Registered Shs ; d. Pardes Biosciences Announces Closing of Tender Offer ; d. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC. According to Pardes Biosciences, Inc.'s latest financial reports and current stock price. The company's current ROE is %. This represents a change of. Pardes Biosciences, Inc. (PRDS): Price and Financial Metrics ; Market Cap, M ; Pardes Biosciences Announces Closing of Tender Offer. CARLSBAD, Calif., Aug. Pardes Biosciences, Inc. - stock earnings. Stock symbol PRDS is outdated, potentially delisted? Maybe it is available on other exchange? Dividends · Price. Should You Buy or Sell Pardes Biosciences Stock? Get The Latest PRDS Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at. About Pardes Biosciences (PRDS) ; Price / earnings ratio. x ; Today's range. — ; Debt / equity. — ; 52 week range. $ - $ ; 5 year debt / equity. —. What do analysts say about Pardes Biosciences? Pardes Biosciences's analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts. Stock/Option, Shares, Shares Change, Price, Cost, Final Share. Anna Hannah. Chief Executive Officer. 01/01/ Sell. Option. K. %. $ $, Pardes Biosciences Inc Similar Stocks · Market price · (%). Pardes Biosciences Inc. NASDAQ:PRDS. Overview. Pardes Biosciences Inc is Stock tickers and charts are · Top 5 NASDAQ Pharma Stocks of · Hand holding.
PRDS — Pardes Biosciences Stock Chart ; Chart Types. Line ; 1D. Periodicity. Daily (1d) ; Draw. Annotations. Text ; Overlays. Trend Signals. Moving Average. The share price as of August 30, is / share. Previously, on August 18, , the share price was / share. This represents an increase of %. Track Pardes Biosciences Inc (PRDS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Get Pardes Biosciences Inc historical price data for PRDS stock. formium.ru has all the historical stock data including the closing price, open, high. by MediPacific, Inc. for between $ and $ in Cash per Share Plus Contingent Value Rights. Pardes Biosciences, Inc. Mon, Jul 17, 8 min read. According to Pardes Biosciences, Inc.'s latest financial reports and current stock price. The company's current Current Ratio is This represents a change. PRDS Pardes Biosciences Inc. $ $ (%). Today. Watchers, Wk Low, $ Wk High, $ Market Cap, $M. Volume, M. Pardes Biosciences (PRDS) said on Monday that MediPacific had agreed to acquire the biopharma firm for between $ and $ in cash per share. Pardes shares. Pardes Biosciences, Inc. (symbol: PRDS) is a cutting-edge biotechnology company dedicated to solving the world's biggest problems through better chemistry.
Pardes Biosciences, Inc. (symbol: PRDS) is a cutting-edge biotechnology company dedicated to solving the world's biggest problems through better chemistry. What Is the Pardes Biosciences Inc Stock Price Today? The Pardes Biosciences Inc stock price today is What Is the Stock Symbol for Pardes Biosciences Inc. Interactive chart of historical stock value for Pardes Biosciences, Inc. over the last 10 years. PRDS was delisted after June 30, and its final market. Based on Macroaxis valuation methodology, the company appears to be overvalued. Pardes Biosciences holds a recent Real Value of $ per share. The biotech company Pardes Biosciences Inc trades as PRDS stock on the Nasdaq All Markets. Pardes is a clinical-stage biopharmaceutical company created by.